β-Casomorphin, human (TFA)

• UNSPSC Description:

  β-Casomorphin, human TFA (Human β-casomorphin 7 TFA) is an opioid peptide, acts as an agonist of opioid receptor[1][2].

• Target Antigen:

  Opioid Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/beta-casomorphin-human-tfa.html

• Purity:

  99.67

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  OC(C(F)(F)F)=O.CC[C@@H]([C@@H](C(O)=O)NC([C@@H]1CCCN1C([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H]2CCCN2C([C@H](CC3=CC=C(C=C3)O)N)=O)=O)CC4=CC=CC=C4)=O)=O)CCC(O)=O)=O)=O)C

• Molecular Weight:

  978.02

• References & Citations:

  [1]Brantl V. Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur J Pharmacol. 1984 Oct 30;106(1):213-4.|[2]Koch G, et al. Opioid activities of human beta-casomorphins. Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):351-4.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported